| SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners (NCT07481344) | University of Michigan Rogel Cancer Center | 2027-05-01 |
| Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT07737769) | University of Michigan Rogel Cancer Center | 2026-11-01 |
| An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer Survivors (NCT07772596) | University of Michigan Rogel Cancer Center | 2026-10-01 |
| Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma (NCT07532525) | University of Michigan Rogel Cancer Center | 2026-09-01 |
| Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial (NCT07526545) | University of Michigan Rogel Cancer Center | 2026-09-01 |
| Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma (NCT07630155) | University of Michigan Rogel Cancer Center | 2026-08-01 |
| Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT07682649) | University of Michigan Rogel Cancer Center | 2026-08-01 |
| Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors (NCT07673614) | University of Michigan Rogel Cancer Center | 2026-08-01 |
| Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial (NCT07529080) | University of Michigan Rogel Cancer Center | 2026-07-01 |
| A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families (NCT07542405) | University of Michigan Rogel Cancer Center | 2026-06-15 |
| Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (NCT06616155) | University of Michigan Rogel Cancer Center | 2026-06-01 |
| Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors (NCT06914479) | University of Michigan Rogel Cancer Center | 2026-05-22 |
| Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP) (NCT06641310) | University of Michigan Rogel Cancer Center | 2026-05-13 |
| A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial (NCT07443943) | University of Michigan Rogel Cancer Center | 2026-04-22 |
| A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment (NCT07365007) | University of Michigan Rogel Cancer Center | 2026-02-23 |
| Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial (NCT07158021) | University of Michigan Rogel Cancer Center | 2026-01-22 |
| A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients (NCT07291414) | University of Michigan Rogel Cancer Center | 2026-01-09 |
| Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer (NCT07094685) | University of Michigan Rogel Cancer Center | 2025-11-18 |
| Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT06784336) | University of Michigan Rogel Cancer Center | 2025-10-15 |
| Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes (NCT06927947) | University of Michigan Rogel Cancer Center | 2025-09-23 |
| An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer (NCT07132645) | University of Michigan Rogel Cancer Center | 2025-09-16 |
| Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial (NCT06866262) | University of Michigan Rogel Cancer Center | 2025-08-15 |
| Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer (NCT06356155) | University of Michigan Rogel Cancer Center | 2025-07-22 |
| Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial (NCT07121595) | University of Michigan Rogel Cancer Center | 2025-07-17 |
| Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors (NCT06941324) | University of Michigan Rogel Cancer Center | 2025-06-23 |
| Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System (NCT07219134) | University of Michigan Rogel Cancer Center | 2025-06-06 |
| Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma (NCT06580054) | University of Michigan Rogel Cancer Center | 2025-03-05 |
| Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery (NCT06094621) | University of Michigan Rogel Cancer Center | 2025-03-01 |
| SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy (NCT07096999) | University of Michigan Rogel Cancer Center | 2025-01-23 |
| Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors (NCT05911269) | University of Michigan Rogel Cancer Center | 2025-01-21 |
| CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer (NCT06915168) | University of Michigan Rogel Cancer Center | 2024-11-13 |
| Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial (NCT06617455) | University of Michigan Rogel Cancer Center | 2024-10-31 |
| Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients (NCT06539468) | University of Michigan Rogel Cancer Center | 2024-10-08 |
| Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors (NCT06442891) | University of Michigan Rogel Cancer Center | 2024-10-01 |
| Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors (NCT06046014) | University of Michigan Rogel Cancer Center | 2024-09-14 |
| Gilteritinib for the Treatment of ALK NSCLC (NCT06225427) | University of Michigan Rogel Cancer Center | 2024-07-25 |
| A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy (NCT06378398) | University of Michigan Rogel Cancer Center | 2024-06-14 |
| A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia (NCT05780879) | University of Michigan Rogel Cancer Center | 2024-06-03 |
| Breast Cancer Resiliency Through Exercise Program (B-REP) (NCT06100263) | University of Michigan Rogel Cancer Center | 2024-05-28 |
| Multicenter Trial of ESK981 in Patients With Select Solid Tumors (NCT05988918) | University of Michigan Rogel Cancer Center | 2024-04-19 |
| Cardiac Rehabilitation to Improve Breast Cancer Outcomes (NCT05867667) | University of Michigan Rogel Cancer Center | 2024-03-19 |
| Living Well With Lymphoma (NCT06047626) | University of Michigan Rogel Cancer Center | 2024-03-07 |
| Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer (NCT06228768) | University of Michigan Rogel Cancer Center | 2024-03-06 |
| Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype (NCT05691400) | University of Michigan Rogel Cancer Center | 2024-03-01 |
| Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer (NCT05996107) | University of Michigan Rogel Cancer Center | 2024-02-27 |
| A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (NCT05901519) | University of Michigan Rogel Cancer Center | 2024-02-16 |
| Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT04845035) | University of Michigan Rogel Cancer Center | 2024-01-01 |
| Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer (NCT06234748) | University of Michigan Rogel Cancer Center | 2023-12-20 |
| Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas (NCT05956041) | University of Michigan Rogel Cancer Center | 2023-12-06 |
| Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe (NCT05965180) | University of Michigan Rogel Cancer Center | 2023-10-16 |
| Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer (NCT06073223) | University of Michigan Rogel Cancer Center | 2023-09-18 |
| Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT05945121) | University of Michigan Rogel Cancer Center | 2023-08-25 |
| Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy (NCT05583422) | University of Michigan Rogel Cancer Center | 2023-08-18 |
| Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas (NCT05926206) | University of Michigan Rogel Cancer Center | 2023-07-01 |
| Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients (NCT05866302) | University of Michigan Rogel Cancer Center | 2023-05-30 |
| A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze) (NCT05894083) | University of Michigan Rogel Cancer Center | 2023-04-27 |
| Localized Leiomyosarcoma Biomarker Protocol (NCT04925089) | University of Michigan Rogel Cancer Center | 2023-04-26 |
| Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms (NCT04858256) | University of Michigan Rogel Cancer Center | 2023-03-29 |
| Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer Patients (NCT05704790) | University of Michigan Rogel Cancer Center | 2023-02-17 |
| Metastatic Leiomyosarcoma Biomarker Protocol (NCT05653388) | University of Michigan Rogel Cancer Center | 2022-12-22 |
| Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study (NCT05764005) | University of Michigan Rogel Cancer Center | 2022-11-09 |
| The Genetic Information and Family Testing (GIFT) Study (NCT05552664) | University of Michigan Rogel Cancer Center | 2022-10-24 |
| CLEAR Care Companion Application (NCT05578898) | University of Michigan Rogel Cancer Center | 2022-08-12 |
| Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) (NCT05169957) | University of Michigan Rogel Cancer Center | 2022-08-09 |
| Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid (NCT05140252) | University of Michigan Rogel Cancer Center | 2022-05-12 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer (NCT05183126) | University of Michigan Rogel Cancer Center | 2022-03-28 |
| Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study (NCT05070299) | University of Michigan Rogel Cancer Center | 2022-03-15 |
| Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging (NCT04852471) | University of Michigan Rogel Cancer Center | 2022-01-05 |
| Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) (NCT05038332) | University of Michigan Rogel Cancer Center | 2021-11-12 |
| An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors (NCT05030792) | University of Michigan Rogel Cancer Center | 2021-10-26 |
| Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy (NCT04497038) | University of Michigan Rogel Cancer Center | 2021-08-06 |
| Lighting Intervention for Cancer-related Fatigue (NCT04827446) | University of Michigan Rogel Cancer Center | 2021-07-15 |
| Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living (NCT04458168) | University of Michigan Rogel Cancer Center | 2021-06-28 |
| Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors (NCT04552418) | University of Michigan Rogel Cancer Center | 2021-06-02 |
| Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) (NCT04748042) | University of Michigan Rogel Cancer Center | 2021-05-28 |
| Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (NCT04848337) | University of Michigan Rogel Cancer Center | 2021-05-25 |
| Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors (NCT04827459) | University of Michigan Rogel Cancer Center | 2021-05-12 |
| Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias (NCT04754399) | University of Michigan Rogel Cancer Center | 2021-04-16 |
| Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications (NCT04595851) | University of Michigan Rogel Cancer Center | 2021-03-26 |
| Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program (NCT04616651) | University of Michigan Rogel Cancer Center | 2021-03-25 |
| Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer (NCT04703920) | University of Michigan Rogel Cancer Center | 2021-03-04 |
| Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients (NCT04503668) | University of Michigan Rogel Cancer Center | 2020-12-28 |
| Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients (NCT04773197) | University of Michigan Rogel Cancer Center | 2020-11-30 |
| A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (NCT04194554) | University of Michigan Rogel Cancer Center | 2020-11-06 |
| Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer (NCT04396808) | University of Michigan Rogel Cancer Center | 2020-11-05 |
| Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT04574856) | University of Michigan Rogel Cancer Center | 2020-11-04 |
| Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors (NCT04510311) | University of Michigan Rogel Cancer Center | 2020-10-19 |
| Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy (NCT04140162) | University of Michigan Rogel Cancer Center | 2020-10-05 |
| Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer (NCT04272645) | University of Michigan Rogel Cancer Center | 2020-10-01 |
| A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients (NCT04480541) | University of Michigan Rogel Cancer Center | 2020-09-18 |
| Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy. (NCT04518748) | University of Michigan Rogel Cancer Center | 2020-09-16 |
| Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation (NCT04094844) | University of Michigan Rogel Cancer Center | 2020-09-08 |
| Testing the Effect of Mindfulness for Prostatectomy Outcomes (NCT04727710) | University of Michigan Rogel Cancer Center | 2020-08-26 |
| Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma (NCT04477200) | University of Michigan Rogel Cancer Center | 2020-08-05 |
| Altering Lipids for Tolerance of Aromatase Inhibitor Therapy (NCT04268134) | University of Michigan Rogel Cancer Center | 2020-07-28 |
| Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma (NCT03617484) | University of Michigan Rogel Cancer Center | 2020-07-01 |
| Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) (NCT04203160) | University of Michigan Rogel Cancer Center | 2020-06-23 |
| Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma (NCT04431635) | University of Michigan Rogel Cancer Center | 2020-06-15 |
| Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma (NCT04076579) | University of Michigan Rogel Cancer Center | 2020-03-17 |